FDA approves controversial Biogen Alzheimer's drug
(Reuters) - U.S. regulators on Monday approved Biogen Inc's aducanumab as the first treatment to address an underlying cause of Alzheimer's disease despite controversy over mixed c…
More from Piedmont Triad
WGHP Fox 8 High Point
New rule could impact your next delayed or canceled flight
Piedmont Triad
•
1m ago
WGHP Fox 8 High Point
1 seriously injured and another killed in Winston-Salem shooting
Piedmont Triad
•
1m ago
Winston-Salem Journal | Sports
Dawgs claim Cabral off waivers, place Spinale on IR
Piedmont Triad
•
11h ago
Winstom-Salem Journal
Winston-Salem protesters urge voter turnout at No Kings rally
Piedmont Triad
•
16h ago
Greensboro News & Record
Watch Now: Greensboro No Kings event held to get out the vote
Piedmont Triad
•
16h ago
Greensboro News & Record
No Kings protesters in Greensboro say they are worried Trump may try to interfere in election
Piedmont Triad
•
16h ago